In-situ forming chitosan implant-loaded with raloxifene hydrochloride and bioactive glass nanoparticles for treatment of bone injuries: Formulation and biological evaluation in animal model
- 30 April 2020
- journal article
- research article
- Published by Elsevier BV in International Journal of Pharmaceutics
- Vol. 580, 119213
- https://doi.org/10.1016/j.ijpharm.2020.119213
Abstract
No abstract availableKeywords
This publication has 43 references indexed in Scilit:
- Sustained release of avastin® from polysaccharides cross-linked hydrogels for ocular drug deliveryInternational Journal of Biological Macromolecules, 2013
- Smart gelation of chitosan solution in the presence of NaHCO3 for injectable drug delivery systemInternational Journal of Pharmaceutics, 2011
- Bioactive glass in tissue engineeringActa Biomaterialia, 2011
- Chitosan Composites for Bone Tissue Engineering—An OverviewMarine Drugs, 2010
- Honokiol Nanoparticles in Thermosensitive Hydrogel: Therapeutic Effects on Malignant Pleural EffusionACS Nano, 2009
- Bioactive Glass Scaffolds for Bone RegenerationElements, 2007
- Rabbit pilot study on the resorbability of three-dimensional bioactive glass fibre scaffoldsActa Biomaterialia, 2006
- Novel injectable neutral solutions of chitosan form biodegradable gels in situBiomaterials, 2000
- Comparison of in vitro dissolution profiles by calculating mean dissolution time (MDT) or mean residence time (MRT)International Journal of Pharmaceutics, 1993
- Radiation sterilization of chitosan sealant for vascular prosthesesJournal of Radioanalytical and Nuclear Chemistry, 1992